{"nctId":"NCT01060072","briefTitle":"Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery","startDateStruct":{"date":"2010-02"},"conditions":["Inflammation","Pain"],"count":407,"armGroups":[{"label":"Loteprednol etabonate","type":"EXPERIMENTAL","interventionNames":["Drug: Loteprednol etabonate"]},{"label":"Vehicle","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Vehicle of Loteprednol Etabonate"]}],"interventions":[{"name":"Loteprednol etabonate","otherNames":[]},{"name":"Vehicle of Loteprednol Etabonate","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects who are at least 18 years of age.\n* Subjects who are candidates for routine, uncomplicated cataract surgery.\n\nExclusion Criteria:\n\n* Subjects who have known hypersensitivity or contraindication to the study drug or components.\n* Subjects with a severe/serious ocular condition, or any other unstable medical condition, that in the investigator's opinion may preclude study treatment or follow-up.\n* Subjects with elevated intraocular pressure (\\>/=21mm Hg), uncontrolled glaucoma, or being treated for glaucoma in the study eye.\n* Subjects who are monocular or have pinholed Snellen visual acuity (VA) 20/200 or worse in the non-study eye.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Resolution of Anterior Chamber Cells.","description":"Participants with complete resolution of anterior chamber cells(ACC). Cells were graded on a 0-4 scale, where 0=no cells and 4=\\>30 cells","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"64","spread":null},{"groupId":"OG001","value":"28","spread":null}]}]}]},{"type":"PRIMARY","title":"Grade 0 Pain","description":"Participants with no pain, graded on a 0-5 scale, 0=no pain and 5=severe pain","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"156","spread":null},{"groupId":"OG001","value":"92","spread":null}]}]}]},{"type":"SECONDARY","title":"Resolution of Anterior Chamber Cells","description":"Participants with complete resolution of anterior chamber cells(ACC). Cells were graded on a 0-4 scale, where 0=no cells and 4=\\>30 cells","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"64","spread":null},{"groupId":"OG001","value":"28","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"116","spread":null},{"groupId":"OG001","value":"61","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"114","spread":null},{"groupId":"OG001","value":"59","spread":null}]}]}]},{"type":"SECONDARY","title":"Grade 0 Pain","description":"Participants with no pain, graded on a 0-5 scale, 0= no pain and 5=severe pain","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"139","spread":null},{"groupId":"OG001","value":"93","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"156","spread":null},{"groupId":"OG001","value":"92","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"160","spread":null},{"groupId":"OG001","value":"89","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"151","spread":null},{"groupId":"OG001","value":"79","spread":null}]}]}]},{"type":"SECONDARY","title":"Resolution of Anterior Chamber Flare","description":"Complete resolution of flare, scored on a scale of 0-4 were 0=none and 4=very severe.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"93","spread":null},{"groupId":"OG001","value":"64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"134","spread":null},{"groupId":"OG001","value":"72","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"162","spread":null},{"groupId":"OG001","value":"90","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"143","spread":null},{"groupId":"OG001","value":"75","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":206},"commonTop":["Anterior Chamber Inflammation","Eye Pain"]}}}